BCM
DRRX

Bayesian Capital Management’s DURECT Corp DRRX Stock Holding History

Bayesian Capital Management’s Portfolio DRRX Stock Details DRRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,310
Closed -$20K – 584
2020
Q1 		$20K Buy
+1,310
New +$25.1K ﹤0.01% 748

Other funds holding DRRX

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

Bayesian Capital Management's DRRX Position: Q2 2020 in Review

Bayesian Capital Management sold out of DURECT Corp (DRRX) in Q2 2020, closing a stake of 1,310 shares — an estimated $20K sold.

Bayesian Capital Management first reported a position in DRRX in Q1 2020 and held it in 1 quarter. The position peaked at $20K in Q1 2020. 111 funds tracked by Wall St. Rank hold DRRX as of Q2 2020.

  • Bayesian Capital Management reported no remaining DURECT Corp position as of Q2 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 1,310 DURECT Corp shares in Q2 2020, an estimated $20K.
  • Bayesian Capital Management first reported a position in DURECT Corp in Q1 2020 and held it in 1 quarter.
  • Bayesian Capital Management's DURECT Corp position peaked at $20K in Q1 2020.
  • 111 funds tracked by Wall St. Rank held DURECT Corp as of Q2 2020.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.